Previous studies demonstrated that the high-mannose oligosaccharide N linked to the Chlamydia major outer membrane protein inhibited the attachment and infectivity of the organism. The present study showed that cleavage of the glycan with N-glycanase decreased the attachment and infectivity of chlamydial organisms in human epithelial and endothelial cells.
Chlamydiae are obligate intracellular bacteria. The uptake of chlamydial elementary bodies (EBs) by nonphagocytic cells is thought to be mediated by receptor-mediated endocytosis (16) . Several mechanisms by which chlamydiae attach and enter host cells and various ligands that facilitate attachment have been proposed. These ligands include glycosaminoglycans (GAGs) (17) , the major outer membrane protein (MOMP) (11) , and heat shock protein 70 (8) . Our studies have focused on what role high-mannose oligosaccharide glycan plays in attachment and infectivity (6) . These studies were based on the findings that Chlamydia trachomatis MOMP is glycosylated (12) and the carbohydrate structure is an N-linked high-mannose oligosaccharide (6) . Hapten inhibition assays with structurally defined oligosaccharides showed that attachment and infectivity of C. trachomatis, C. pneumoniae, and C. psittaci in HeLa cells were inhibited by high-mannose oligosaccharides, suggesting that the glycan moiety of chlamydiae mediates attachment and infectivity (6) . The present study investigated if removal of the surface-exposed glycan from live chlamydial organisms affects their infectivity.
Chlamydial organisms purified by density gradient centrifugation were incubated with either N-glycanase (PNGase F) or O-glycanase (endo-␣-acetylgalactosaminidase), with no detectable proteolytic activity (Sigma, St. Louis, Mo.), in 5 mM potassium phosphate buffer, pH 7.5, for 3 h at room temperature. N-glycanase cleaves N-linked oligosaccharides and Oglycanase cleaves O-linked oligosaccharides from the protein backbone. Subsequently, organisms were pelleted, washed once, and resuspended in chlamydial transport medium SPG (5) . Positive controls were organisms incubated in buffer alone.
Infectivity was assayed in human epithelial HL (2) or endothelial HMEC-1 (1) cell monolayers prepared in 24-well culture plates containing a 12-mm-diameter round coverslip. Glycanase-treated organisms were inoculated into six wells per treatment at a multiplicity of infection of 10 for HL cells and of 20 for HMEC-1 cells. After 2 h of absorption at 37°C on a rocking platform, the inoculum was removed and culture medium was added. Infected cells were incubated at 37°C for 2 days with C. trachomatis and C. psittaci and for 3 days with C. pneumoniae. Three wells were used for the infectivity assay (first passage), and the remaining three wells were harvested and passed to HL cells (second passage) to assay the growth of organisms in the first passage by determining the number of infectious organisms produced (burst size). In the second passage, centrifugation was applied during absorption and cycloheximide was added to the culture medium for incubation of inoculated cells (5) . Infectivity was quantified by counting inclusions following fluorescent-antibody staining and expressed as the number of inclusion forming units per milliliter.
Organisms metabolically labeled with [ 35 S]methionine were used for assaying attachment (7). The binding assay was conducted at 4 and 37°C. At 4°C, organisms attach to but do not enter the host cells, while attachment and internalization do occur at 37°C. After 2 h of absorption in triplicate wells, inocula were removed and monolayers were washed three times with phosphate-buffered saline. Cells were scraped off with 0.5 ml of phosphate-buffered saline, disrupted by sonication, and transferred to scintillation vials, after which 5 ml of Dupont LSC scintillation cocktail (Biotechnology System, Boston, Mass.) was added and radioactivity was counted.
N-glycanase treatment inhibited the infectivity of C. pneumoniae AR-39 for HL and HMEC-1 cells in a dose-dependent manner (Fig. 1) . The growth (burst size) of C. pneumoniae in these cells was also inhibited but at higher concentrations (greater than 90% inhibition at Ն10 U in HL cells and at 30 U in HMEC-1 cells). Both infectivity and growth of C. trachomatis E/UW-5/Cx and L 2 /434/Bu and C. psittaci 6BC were also inhibited by N-glycanase treatment ( Table 1) . Inhibition of all species following treatment with 2.5 U was partial in HL (Յ34%) and HMEC-1 (Յ40%) cells. C. pneumoniae and C. trachomatis L 2 were the most susceptible to N-glycanase treatment, followed by C. trachomatis E and C. psittaci ( Table 1) . As expected (12) , O-glycanase (0.02 U) had no effect on any of the above strains (data not shown).
Attachment of radiolabeled organisms to both HL and HMEC-1 cells was significantly inhibited at 4°C (Table 2 ). C. pneumoniae was inhibited the most, followed by C. trachomatis L 2 and C. trachomatis E, in HL and HMEC-1 cells, respectively. With the exception of C. pneumoniae and HMEC-1 cells, greater inhibition was observed at 37°C than at 4°C (Table 2).
This study confirmed our previous studies showing that chlamydiae use the surface-exposed carbohydrate structure for infection of mammalian host cells and that the oligosaccharide is N linked to the protein backbone (6) . The strain differences observed in susceptibility to N-glycanase treatment had also been observed with the binding of EBs to GAGs (9, 10). For example, the attachment of C. trachomatis E was not affected by GAG, while that of C. trachomatis L 2 was (3). This finding is similar to the present study showing the greater effect of N-glycanase treatment on C. trachomatis L 2 than on C. trachomatis E. It has been shown that the attachment of C. psittaci GPIC is GAG dependent; however, GAG does not prevent productive infections (4) . This observation is compatible with the present finding that C. psittaci can also use the mannose oligosaccharide for infection.
In this study, EBs were incubated with N-glycanase at pH 7.5 for 3 h at room temperature, which are not optimal conditions for glycan removal. In previous studies, the glycan was released from gel-purified, glycanated MOMP by treatment with 0.3 U at pH 8.6 for 48 h at 37°C, which resulted in maximum recovery of glycan for use in the infectivity inhibition assay (6, 13) . This treatment is not applicable to live chlamydial EBs, as it results in inactivation of the organism. To compensate for the shorter duration of treatment and the use of neutral pH, the concentration of N-glycanase was increased to 30 U. Nevertheless, a significant reduction of infectivity was obtained.
Any effect of proteinase contamination of N-glycanase could be ruled out, as inhibitory effects were identical regardless of whether the proteinase inhibitor phenylmethylsulfonyl fluoride (Sigma) was present or not during treatment and no proteolytic activity was observed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis following the treatment of organisms.
Metabolic labeling studies demonstrated that the glycan plays a role in both attachment to the host cell and internalization, as an increased inhibitory effect was observed at 37°C in comparison to that seen at 4°C (Table 2 ). An additional effect of N-glycanase treatment on growth is suggested by the greater inhibition of infectivity observed on the basis of inclusion counts (Table 1 versus Table 2 ). The greater inhibition of infectivity and the lower percent inhibition of attachment by N-glycanase treatment are analogous to those observed previously with high-mannose oligosaccharides in hapten inhibition studies (6) . These results are compatible with the current concept (17) that EBs initially bind to the GAG receptor, which leads to the specific ligand-receptor-mediated interaction for entry (9, 10, 18) .
We have previously reported that C. trachomatis contains three glycoproteins with molecular masses of 40, 32, and 18 kDa (12, 14, 15) . Therefore, the present study cannot differentiate which glycoprotein(s) is involved in infectivity. However, it is believed that MOMP plays a major role in adhesion and infectivity of chlamydial organisms (9, 10) .
In summary, N-glycanase treatment inhibited both attachment and infectivity and susceptibility varied among strains and between cell types. 
